Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics
Narciso Couto, Zubida M. Al‐Majdoub, Brahim Achour, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 2, pp. 632-647
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine
Narciso Couto, Zubida M. Al‐Majdoub, Stephanie Gibson, et al.
Drug Metabolism and Disposition (2020) Vol. 48, Iss. 4, pp. 245-254
Open Access | Times Cited: 88
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Yurong Lai, Xiaoyan Chu, Li Di, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2751-2777
Open Access | Times Cited: 59
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108459-108459
Closed Access | Times Cited: 30
A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism
Jingxuan Chen, Sibo Jiang, Jin Wang, et al.
Drug Metabolism Reviews (2019) Vol. 51, Iss. 2, pp. 178-195
Closed Access | Times Cited: 69
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment
Eman El‐Khateeb, Brahim Achour, Zubida M. Al‐Majdoub, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 9, pp. 3563-3577
Open Access | Times Cited: 53
Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity
Christine Wegler, Jacek R. Wiśniewski, Ida Robertsen, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 111, Iss. 5, pp. 1142-1154
Open Access | Times Cited: 35
The SLIT/ROBO Pathway in Liver Fibrosis and Cancer
Sreenivasulu Basha, Brady Jin-Smith, Chunbao Sun, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 785-785
Open Access | Times Cited: 18
Differential Tissue Abundance of Membrane-Bound Drug Metabolizing Enzymes and Transporter Proteins by Global Proteomics
Dilip Kumar Singh, Deepak Ahire, Dmitri R. Davydov, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 11, pp. 1152-1160
Open Access | Times Cited: 8
Comparative Proteomics Analysis of Human Liver Microsomes and S9 Fractions
Xinwen Wang, Bing He, Jian Shi, et al.
Drug Metabolism and Disposition (2019) Vol. 48, Iss. 1, pp. 31-40
Open Access | Times Cited: 48
Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Florian Klomp, Christoph Wenzel, Marek Droździk, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1201-1201
Open Access | Times Cited: 46
Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics
Márton Kiss, Richard Mbasu, Johan Nicolaï, et al.
Drug Metabolism and Disposition (2021) Vol. 49, Iss. 12, pp. 1038-1046
Open Access | Times Cited: 36
CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/β-catenin signaling
Lili Zhu, Xiaobei Yang, Jingyu Feng, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Cell‐type‐resolved proteomic analysis of the human liver
Magnus Ölander, Jacek R. Wiśniewski, Per Artursson
Liver International (2020) Vol. 40, Iss. 7, pp. 1770-1780
Open Access | Times Cited: 38
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters
Jiapeng Li, Hao‐Jie Zhu
Molecules (2020) Vol. 25, Iss. 11, pp. 2718-2718
Open Access | Times Cited: 38
Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs
Sarah Alrubia, Jialin Mao, Yuan Chen, et al.
Clinical Pharmacokinetics (2022) Vol. 61, Iss. 10, pp. 1365-1392
Open Access | Times Cited: 19
The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK Modeling
Mo’tasem M. Alsmadi, Nasir Idkaidek
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 281-300
Closed Access | Times Cited: 12
Transporter Expressions as Part of Required Scaling Factor to Support In vitro In vivo Extrapolation for Blood-Brain Barrier Drug Permeability
Zubida M. Al‐Majdoub, Jonathan Cheong, Kunihiko Mizuno, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107022-107022
Open Access
Sex-specific UGT expression and function: prevalence, potential mechanisms and significance
Robyn Meech, Dong Hu, Julie-Ann Hulin, et al.
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Oleanolic acid-targeted LAMP1 mediates autophagy and lysosome to alleviate high-fat-induced hepatic lipid deposition
Kai Yu, Ruijie Guo, Delun Huang, et al.
Aquaculture (2025), pp. 742656-742656
Closed Access
Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics
Zubida M. Al‐Majdoub, Narciso Couto, Brahim Achour, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 4, pp. 1136-1146
Open Access | Times Cited: 28
Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes
Eman El‐Khateeb, Zubida M. Al‐Majdoub, Amin Rostami‐Hodjegan, et al.
Drug Metabolism and Disposition (2021) Vol. 49, Iss. 8, pp. 610-618
Open Access | Times Cited: 24
Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics
Zubida M. Al‐Majdoub, Daniel Scotcher, Brahim Achour, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 5, pp. 1389-1400
Open Access | Times Cited: 24
Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development
Raymond K. Hau, Stephen H. Wright, Nathan J. Cherrington
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 4, pp. 780-794
Closed Access | Times Cited: 10
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice
Eman El‐Khateeb, Areti‐Maria Vasilogianni, Sarah Alrubia, et al.
Pharmacology & Therapeutics (2019) Vol. 203, pp. 107397-107397
Open Access | Times Cited: 26
Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin
Zubida M. Al‐Majdoub, Brahim Achour, Narciso Couto, et al.
FEBS Letters (2020) Vol. 594, Iss. 23, pp. 4134-4150
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top